Anti-Human CTLA4 (IB8) Antibody

Human

CTLA-4

1.0 - 5.0 mg/ml

Human IgG1 Kappa

Humanized

0.1mg

P16410

Blue ice

CTLA-4 is an inhibitory checkpoint receptor that competes with CD28 to limit early T-cell activation and is a foundational target in cancer immunology research. Clone IB8 is a human IgG1-kappa monoclonal antibody directed against human CTLA-4, suited to checkpoint-blockade and T-cell activation studies. Anti-CTLA-4 clone IB8 is supplied in a low-endotoxin format suitable for in vivo use and produced in scalable milligram to gram quantities for bulk and high-throughput laboratories. With dependable lot-to-lot consistency, IB8 is a robust reagent for tumour immunology and preclinical checkpoint research. It is a non-therapeutic product intended strictly for research use only.

Ctla4, Cytotoxic T-lymphocyte protein 4, CD152

IB8

Detects human CTLA-4.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.

Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –20°C or –80°C. Avoid Repeated Freeze Thaw Cycles.

This antibody is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.